Literature DB >> 23642721

Guillain-Barré syndrome and variants.

Mazen M Dimachkie1, Richard J Barohn.   

Abstract

Guillain-Barré syndrome (GBS) is characterized by rapidly evolving ascending weakness, mild sensory loss, and hyporeflexia or areflexia. Acute inflammatory demyelinating polyneuropathy was the first to be recognized over a century ago and is the most common form of GBS. Axonal motor and sensorimotor variants have been described in the last three decades and are mediated by molecular mimicry targeting peripheral nerve motor axons. Other rare phenotypic variants have been recently described with pure sensory variant, restricted autonomic manifestations, and the pharyngeal-cervical-brachial pattern. It is important to recognize GBS and its variants because of the availability of equally effective therapies in the form of plasmapheresis and intravenous immunoglobulins.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642721      PMCID: PMC3939842          DOI: 10.1016/j.ncl.2013.01.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  80 in total

1.  Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation.

Authors:  J Pritchard; R Mukherjee; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands.

Authors:  R Van Koningsveld; P A Van Doorn; P I Schmitz; C W Ang; F G Van der Meché
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

4.  Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.

Authors:  Eleni E Magira; Miltiadis Papaioakim; Irving Nachamkin; Arthur K Asbury; Chun Y Li; Tony W Ho; John W Griffin; Guy M McKhann; Dimitri S Monos
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group.

Authors:  L H Visser; P I Schmitz; J Meulstee; P A van Doorn; F G van der Meché
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

6.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

7.  Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R A C Hughes; E F M Wijdicks; R Barohn; E Benson; D R Cornblath; A F Hahn; J M Meythaler; R G Miller; J T Sladky; J C Stevens
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

8.  Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

Authors:  H J Willison; J Veitch; G Paterson; P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

Authors:  T Lasky; G J Terracciano; L Magder; C L Koski; M Ballesteros; D Nash; S Clark; P Haber; P D Stolley; L B Schonberger; R T Chen
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

10.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  62 in total

1.  A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome.

Authors:  Lennie Lynn Chua de Castillo; Jose Danilo Bengzon Diestro; Katrina Hannah Dizon Ignacio; Paul Matthew Dimaguila Pasco
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 2.  Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.

Authors:  Luanna Yang; Eveline Y Wu; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

3.  Acute Bilateral Phrenic Neuropathy: from Diabetes Mellitus to Focal Guillain-Barré Syndrome.

Authors:  Alina Dima; Laura Dumitrescu; Ioana Berza; Marius Ioan Balea; Ayghiul Mujdaba-Elmi; Bogdan Ovidiu Popescu; Cristian Baicus
Journal:  Maedica (Bucur)       Date:  2016-03

Review 4.  Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.

Authors:  Preeyam Patel; John F Kearney
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

5.  Rare variant of Guillain-Barré syndrome after chikungunya viral fever.

Authors:  Sajid Hameed; Sara Khan
Journal:  BMJ Case Rep       Date:  2019-04-23

Review 6.  [Polyneuropathy in the elderly].

Authors:  Wolfgang Löscher; Bernhard Iglseder
Journal:  Z Gerontol Geriatr       Date:  2017-04-28       Impact factor: 1.281

Review 7.  Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.

Authors:  Mohamed Kazamel; Robert J Desnick; John G Quigley
Journal:  Curr Neurol Neurosci Rep       Date:  2020-10-07       Impact factor: 5.081

Review 8.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

9.  Pattern-recognition approach to neuropathy and neuronopathy.

Authors:  Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2013-05       Impact factor: 3.806

10.  Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barré Syndrome?

Authors:  Hussein Algahtani; Bader Shirah; Khalid Alrefaei; Mohammed Albassam; Nawal Abdelghaffar
Journal:  Neurohospitalist       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.